XTL3710

N/A

Report date: 2025/08/19 11:14:35
NME

Base Information

Drug NameXTL3710
Drug Alias NameXTL3710XTL-3710
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRenal Insufficiency, ChronicDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShaanxi Micot Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShaanxi Micot Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, ChronicDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A